SMS Pharmaceuticals share news, announcements and annual reports
NSE: SMSPHARMABSE: 532815Pharmaceuticals & BiotechnologySmall Cap
SMS Pharmaceuticals Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2007
Last close ₹504.15down ₹7.20 (1.41%)BSE ₹504.25
Share price at the NSE close on 2 Nov 2026. Previous close ₹511.35.
2 Nov: open ₹511.00, high ₹514.80, low ₹471.25
52-week range of traded prices to 2 Nov 2026
₹270.10Low, 24 Nov 2025₹525.00High, 30 Oct 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,721 Cr920th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 45.98
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.46
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,24,26833.2% delivered
SMS Pharmaceuticals share news and announcements
718 announcements, routine notices left out, newest first. Page 12 of 15.
Nov 2014
5 Nov · Board meeting
Inter alia, to consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2014 with limited review report.
Oct 2014
Sep 2014
Aug 2014
26 Aug · Meeting
Register of Members and the share transfer books of the Company will remain closed from September 25, 2014 to September 30, 2014 (both days inclusive) for the purpose of payment of Dividend and convening of the Annual General Meeting on September 30, 2014.26 Aug · Board meeting
Board has taken the following decisions in its meeting held on August 26, 2014: 1. Approved the Directors' Report. 2. Approved and recommended for Re-appointment of M/s. Rambabu & Co., Chartered Accounts as Sole Auditors of the Company for a period of 1 (one) year. 3. Approved Mr. C. Sudhir Babu, Practicing Company Secretary as Scrutinizer for conduct of e-voting process.18 Aug · Board meeting
Inter alia, to consider the following items of Agenda: 1. To approve the draft Directors' Report. 2. To approve the draft Notice of the 26th Annual General Meeting of the Company. 3. To fix the time, date, book closure and venue to convene the 26th Annual General Meeting of the Company. 4. To re-appoint the Statutory Auditors.1 Aug · Board meeting
Inter alia, to consider the Un-audited Financial results of the Company for the quarter ended June 30, 2014 with limited reveiw report.
Jun 2014
4 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2014 has recommended dividend of Rs.2-00 (Rupee Two only) per equity share of Rs.10/-each on the paid up share capital of the company for the year 2013-14.
May 2014
30 May · Results
20 May · Board meeting
Interalia, to consider the followings:- (1) To consider, approve and take on record the Audited Annual Accounts for the year ended March 31, 2014; (2) To consider recommendation of the Dividend, if any, subject to approval of the shareholders at the ensuing Annual General Meeting of the Company.
Feb 2014
11 Feb · Results
3 Feb · Board meeting
Interalia, to consider the Un-audited Financial Results of the Company for the quarter ended December 31, 2013 with limited review report.
Nov 2013
11 Nov · Results
Oct 2013
31 Oct · Board meeting
Interalia, to consider the Un-audited Financial Results of the Company for the quarter ended September 30, 2013 with limited review report.1 Oct · Disclosure of Voting Pattern - Clause 35A
Aug 2013
16 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 13, 2013 has taken the following decisions: 1. Considered and approved Re-appointment of Mr. Ramesh Babu Potluri as CMD for a period of 3 years w.e.f. December 01, 2013 subject to necessary approvals. 2. Considered and approved Re-appointment of Mr. TVVSN Murthy as VC&JMD for a period of 3 years w.e.f. December 01, 2013 subject to necessary approvals. 3. Considered and approved Re-appointment of Mr. T. V. Praveen as Vice-President (Marketing) for a further period of 3 years w.e.f. January 01, 2014 subject to necessary approvals. 4. Considered and approved appointment of Mr. Vamsi Krishna Potluri as Vice-President (Operations) for a period of 3 years w.e.f. August 09, 2013 subject to necessary approvals. 5. Considered and approved to invest upto Rs. 30.00 crores in M/s. VKT Pharma Private Limited by way of Equity participation subject to necessary approvals. 6. Considered and authorized the CMD to evaluate the possibilities of the low-performing assets to consolidate with existing facilities to reduce the operating overheads and also for better utilization of the said facilities.16 Aug · Meeting
Register of Members and the share transfer books of the Company will remain closed from September 25, 2013 to September 30, 2013 (both days inclusive) for the purpose of payment of Dividend and convening of the Annual General Meeting on September 30, 2013.2 Aug · Board meeting
Inter alia, to consider the followings: (1) To consider the un-audited financial results for the quarter ended on June 30, 2013 with limited review report. (2) To consider the Re-appointment of Mr. Ramesh Babu Potluri as Chairman & Managing Director of the Company for a further period of 5 years with effect from December 01, 2013. (3) To consider the Re-appointment of Mr. TVVSN Murthy as Vice-Chairman & Joint Managing Director of the Company for a further period of 5 years with effect from December 01, 2013. (4) To consider the Re-appointment of Mr. T. V. Praveen as Vice-President (Marketing) of the Company for a further period of 5 years with effect from January 01, 2014. (5) To consider the appointment of Mr. Vamsi Krishna Potluri as Vice-President (Operations) of the Company. (6) To Invest in M/s. VKT Pharma Private Limited. (7) To fix the date, time and venue of Annual General Meeting of the Company. (8) To fix the date of book closure for the purpose of conduct of Annual General Meeting and payment of dividend.
Jul 2013
30 Jul · Post Buyback Public Announcement
Jun 2013
May 2013
30 May · Dividend
Board of Directors of the Company at its meeting held on May 29, 2013, inter alia, has taken the following decisions : Recommended dividend of Rs. 2.00 (Rupee Two Only) per equity share of Rs. 10/- each on the paid up share capital of the company for the year 2012-13.30 May · Results
24 May · Updates
Income-tax Authorities have conducted a search of the records of the Company at all Manufacturing Units, Registered office, and Corporate Office on May 23, 2013.The Company has extended full co-operation to the Income-tax authorities and they have collected the necessary information.11 May · Board meeting
Interalia, to consider the followings :- (1) To consider, approve and take on record the Audited Annual Accounts for the year ended March 31, 2013; (2) To consider recommendation of the Dividend, if any, subject to approval of the shareholders at the ensuing Annual General Meeting of the Company.
Mar 2013
Feb 2013
26 Feb · Board meeting
18 Feb · Board meeting
Interalia, to consider the proposal for Buy Back of Company's Shares in accordance with Section 77A of the Companies Act, 1956 and the Article of the Association of the Company.